X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
BIOCON LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

BIOCON LIMITED  (BICN)


Here is the latest financial fact sheet of Biocon Ltd. For more details, see the Biocon Ltd quarterly results and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
biocon ltd - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 1,130.7       No. of shares m 200.00
    Mkt Cap Rs m 226,130       % ch % -0.5
    Vol '000 14.6       % ch week % 0.9
    P/E X 39.2       % ch 1-mth % 1.4
    P/CF X 18.6       % ch 12-mth % 143.8
    EPS (TTM) Rs 28.9       52 week H/L Rs 1,150.0/463.3
(As on Mar 23, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs385307497554496 
Low Rs243211265407397 
Sales per share (Unadj.) Rs104.3124.3143.9154.5174.3 
Earnings per share (Unadj.) Rs16.925.420.724.944.8 
Diluted earnings per shareRs16.925.420.724.944.8 
Cash flow per share (Unadj.) Rs25.634.430.935.956.9 
Dividends per share (Unadj.) Rs5.007.505.005.005.00 
Adj. dividends per shareRs5.007.505.005.005.00 
Dividend yield (eoy) %1.62.91.31.01.1 
Book value per share (Unadj.) Rs113.6134.7151.3163.5202.8 
Adj. book value per shareRs113.6134.7151.3163.5202.8 
Shares outstanding (eoy) m200.00200.00200.00200.00200.00 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.02.12.63.12.6 
Avg P/E ratio x18.610.218.419.310.0 
P/CF ratio (eoy) x12.27.512.313.47.8 
Price / Book Value ratio x2.81.92.52.92.2 
Dividend payout %29.629.524.220.111.2 
Avg Mkt Cap Rs m62,80051,79076,19096,08089,220 
No. of employees `0006.36.77.37.54.4 
Total wages/salary Rs m3,0763,8944,6635,3346,363 
Avg. sales/employee Rs Th3,336.83,694.53,936.14,119.77,894.5 
Avg. wages/employee Rs Th491.9578.9637.9711.21,441.2 
Avg. net profit/employee Rs Th541.2756.5566.1663.22,029.7 
  INCOME DATA
Net Sales Rs m20,86524,85328,77330,89834,854 
Other income Rs m618527559531845 
Total revenues Rs m21,48325,38029,33231,42935,699 
Gross profit Rs m5,1735,4306,8716,9588,200 
Depreciation Rs m1,7441,7932,0362,2102,423 
Interest Rs m122811789102 
Profit before tax Rs m3,9254,0835,3775,1906,520 
Minority Interest Rs m0-38-170-310-744 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m02,01901,0515,754 
Tax Rs m5419751,0699572,569 
Profit after tax Rs m3,3845,0894,1384,9748,961 
Gross profit margin %24.821.823.922.523.5 
Effective tax rate %13.823.919.918.439.4 
Net profit margin %16.220.514.416.125.7 
  BALANCE SHEET DATA
Current assets Rs m19,99722,40026,38825,62639,932 
Current liabilities Rs m10,1589,89913,79615,54716,276 
Net working cap to sales %47.250.343.832.667.9 
Current ratio x2.02.31.91.62.5 
Inventory Days Days6659485354 
Debtors Days Days8675769186 
Net fixed assets Rs m16,60018,22827,30833,06539,101 
Share capital Rs m1,0001,0001,0001,0001,000 
"Free" reserves Rs m20,74524,07927,04730,77838,591 
Net worth Rs m22,72426,94630,26732,70640,556 
Long term debt Rs m6981,6406,0627,69620,724 
Total assets Rs m39,37244,16157,50663,75484,816 
Interest coverage x33.251.4317.359.364.9 
Debt to equity ratio x00.10.20.20.5 
Sales to assets ratio x0.50.60.50.50.4 
Return on assets %8.911.77.27.910.7 
Return on equity %14.918.913.715.222.1 
Return on capital %17.321.514.414.919.0 
Exports to sales %31.938.037.133.530.7 
Imports to sales %21.522.422.819.720.4 
Exports (fob) Rs m6,6619,45010,66910,33910,717 
Imports (cif) Rs m4,4815,5616,5736,1027,105 
Fx inflow Rs m6,7739,90610,80310,99311,789 
Fx outflow Rs m5,4496,3307,7157,3718,393 
Net fx Rs m1,3243,5763,0883,6223,396 
  CASH FLOW
From Operations Rs m 5,641 4,712 5,607 2,107 5,264 
From Investments Rs m -3,595 -3,758 -9,381 -5,087 -9,540 
From Financial Activity Rs m -1,863 -86 4,260 1,862 10,867 
Net Cashflow Rs m 183 868 486 -1,118 6,591 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for biocon limited

 Share Holding
Indian Promoters : 40.4%
Foreign collaborators : 20.6%
Indian inst/Mut Fund : 8.4%
FIIs : 10.7%
ADR/GDR : 0.0%
Free float : 19.9%
Shareholders : 109,995
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
    E-MAIL: kiran.kumar@biocon.com     WEB: www.biocon.com
    TELEPHONE: (080) 2808 2037     FAX: (080) 2852 3423
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
    AUDITOR: S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.4

More pharmaceuticals Company Fact Sheets:   INDRAPRASTHA MEDICALFULFORD INDIAAUROBINDO PHARMANATCO PHARMAGLENMARK PHARMA


Today's Market

Sensex Closes Firm; NTPC Surges 2.3%(Closing)

Indian share markets continued to trade higher owing to firm global cues with energy stocks leading the gains, while financial stocks and auto stocks bounced back.

Views on news

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Biocon: A Good Quarter (Quarterly Results Update - Detailed)

May 10, 2016

Biocon has announced its 4QFY16 and full year results. The company has reported 16.8% YoY growth in total income and 79.1% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why You Should Try SCOREFASTTM Right Now(Daily Profit Hunter)

Mar 10, 2017

Asad Dossani discusses why SCOREFASTM will be a successful trading strategy

4 Things To Watch Out For After Modi's Landslide Win In UP Polls(Outside View)

Mar 15, 2017

PersonalFN explains why you need to wary while investing in equities despite Modi's UP win.

More

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BIOCON LTD

BIOCON LTD - ACTAVIS COMPARISON

Compare Company With Charts

COMPARE BIOCON LTD WITH

MARKET STATS